Is poor quality of life always present with minimal hepatic encephalopathy?

Liver International

Volumn 31, Issue 7, 2011, Pages 908-910

  Prakash, Ravi K ^a   Mullen, Kevin D ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTULOSE;

ALCOHOL LIVER CIRRHOSIS; COST EFFECTIVENESS ANALYSIS; EDITORIAL; ELECTROENCEPHALOGRAM; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; PSYCHOMETRY; QUALITY OF LIFE; SHORT FORM 36;

FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MALE; QUALITY OF LIFE;

EID: 79960104284     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02532.x     Document Type: Editorial

References (9)

1. Groeneweg M, Quero JC, De Bruijn I, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998; 28: 45-9.
2. Marchesini G, Bianchi G, Amodio P, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001; 120: 170-8.
3. Prasad S, Dhiman RK, Duseja A, et al. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007; 45: 549-59.
4. Wunsch E, Szymanik B, Post M, et al. Minimal hepatic encephalopathy does not impair health related quality of life in cirrhosis: a prospective study. Liver Int 2011; 31: 980-4.
5. Wunsch E, Lockwood A, Mullen K, et al. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-21.
6. Wunsch E, Qiu DK, Ma X, et al. Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy. World J Gastroenterol 2007; 13: 3003-8.
7. Bajaj JS, Wade JB, Sanyal AJ. Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy. Hepatology 2009; 50: 2014-21.
8. Sidhu SS, Goyal O, Mishra BP, et al. Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial). Am J Gastroenterol 2011; 106: 307-16.
9. Prakash R, Mullen KD. Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol 2010; 7: 515-25.